Further Considerations Regarding Molecular Screening and Treatment of Bacterial Vaginosis

JAMA Pediatr. 2024 Jan 1;178(1):94-95. doi: 10.1001/jamapediatrics.2023.4755.

Authors

Adriane Wynn¹, Chelsea Morroni², Jeffrey D Klausner³

Affiliations

¹ Division of Infectious Diseases and Global Public Health, University of California, San Diego.
² Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
³ Keck School of Medicine, University of Southern California, Los Angeles.

PMID: 37930708
DOI: 10.1001/jamapediatrics.2023.4755

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use
Female
Humans
Pregnancy
Pregnancy Complications, Infectious* / prevention & control
Vaginosis, Bacterial* / diagnosis
Vaginosis, Bacterial* / drug therapy
Vaginosis, Bacterial* / microbiology

Substances

Anti-Bacterial Agents

Grants and funding